https://wikimd.org/index.php?action=history&feed=atom&title=Bisantrene 2026-04-27T12:04:54Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=Bisantrene&diff=5369206&oldid=prev 2024-03-06T05:01:29Z

<p>CSV import</p> <p><b>New page</b></p><div>[[File:Bisantrene.png|thumb|{{PAGENAME}}]]&lt;br&gt;&#039;&#039;&#039;Bisantrene&#039;&#039;&#039; is a synthetic [[anthracene]] derivative that has been used in the treatment of various types of [[cancer]]. It is classified as an [[antineoplastic agent]], specifically an [[anthracycline]], and is known for its ability to intercalate [[DNA]], thereby inhibiting [[DNA replication]] and [[RNA synthesis]].<br /> <br /> == History ==<br /> <br /> Bisantrene was first synthesized in the late 1970s as part of a series of anthracene derivatives designed to have antineoplastic activity. Early studies showed that it had activity against a range of [[tumor]] types, including [[leukemia]], [[lymphoma]], and various solid tumors.<br /> <br /> == Mechanism of Action ==<br /> <br /> Bisantrene works by intercalating into DNA, a process in which the drug molecule inserts itself between the base pairs of the DNA helix. This disrupts the normal structure of the DNA and prevents the DNA from being replicated or transcribed into RNA. As a result, the growth of cancer cells is inhibited.<br /> <br /> == Clinical Use ==<br /> <br /> Bisantrene has been used in the treatment of a variety of cancers, including [[acute myeloid leukemia]] (AML), [[non-Hodgkin&#039;s lymphoma]] (NHL), and [[breast cancer]]. It has been shown to be particularly effective in treating AML, with response rates in some studies as high as 80%.<br /> <br /> == Side Effects ==<br /> <br /> Like many antineoplastic agents, bisantrene can have serious side effects. These can include [[nausea]], [[vomiting]], [[hair loss]], and [[bone marrow suppression]]. However, it has been noted that bisantrene causes less [[cardiotoxicity]] than other anthracyclines, which can be a significant advantage in certain patient populations.<br /> <br /> == Current Research ==<br /> <br /> Research into bisantrene is ongoing, with recent studies focusing on its potential use in treating [[pediatric cancers]] and in combination with other drugs to enhance its antineoplastic activity.<br /> <br /> [[Category:Antineoplastic drugs]]<br /> [[Category:Anthracyclines]]<br /> {{Chem-drug-stub}}</div>

Prab